Company Filing History:
Years Active: 2020
Title: David M Tanenbaum: Innovator in Systems Medicine for Personalized Oncology
Introduction
David M Tanenbaum is a notable inventor based in Vienna, VA (US). He has made significant contributions to the field of personalized oncology through his innovative work. His research focuses on integrating patient characteristics with high-throughput research data to enhance cancer treatment.
Latest Patents
David M Tanenbaum holds a patent for a "Systems medicine platform for personalized oncology." This invention is directed towards a web-based platform that facilitates both basic and clinical research activities. It integrates patient characteristics and clinical outcome data with various high-throughput research data in a unified environment. The platform includes a comprehensive collection of bioinformatics and systems biology tools for the analysis and visualization of four major 'omics' types: DNA, mRNA, microRNA, and metabolites, as well as next-generation sequencing. This invention aids in identifying trends and patterns in integrated datasets, thereby facilitating the use of better-targeted therapies for cancer.
Career Highlights
David M Tanenbaum is affiliated with Georgetown University, where he continues to advance research in systems medicine. His work is pivotal in bridging the gap between clinical research and patient care, particularly in oncology.
Collaborations
David has collaborated with esteemed colleagues such as Subha Madhavan and Michael A Harris, contributing to the advancement of personalized medicine.
Conclusion
David M Tanenbaum's innovative contributions to systems medicine exemplify the potential of integrating diverse data types to improve cancer treatment. His work continues to influence the field of personalized oncology significantly.